Compelo Packaging - Latest industry news and analysis is using cookies

ContinueLearn More
Close
Dismiss

Clondalkin major investment broadens UK labels provision

An investment of more than €1 million by Clondalkin Group in the further enhancement of its leading Specialist Packaging Pharma & Healthcare business includes the installation of a Gallus ECS 340 press at Clondalkin Pharma & Healthcare Kimbolton near Cambridge, UK.

An investment of more than €1 million by Clondalkin Group in the further enhancement of its leading Specialist Packaging Pharma & Healthcare business includes the installation of a Gallus ECS 340 press at Clondalkin Pharma & Healthcare Kimbolton near Cambridge, UK.

According to the producer of high value added packaging, the new Gallus 9 colour UV press, which features 340mm wide print, cold foil and reverse print capabilities, will help to expand the company’s provision of high quality and efficient label production capabilities.

At Clondalkin Pharma & Healthcare Hull, in the north of England, significant upgrades to two existing presses have also been completed to further strengthen the company’s capabilities in multi ply labels.

A Gallus EM 260 flexo press has been upgraded with a new re-register unit plus two additional print heads to enable label production in 9 colours and up to 4 layers.

Upgrades to an MPS flexo press include an additional print head taking it up to 10 colours, and a new web shifting unit allowing production of a 5 ply label in a single pass.

“The investment creates two distinctive but complementary site offerings,” says Malcolm Farnan, European sales director from Clondalkin Group Specialist Packaging Division.

“Hull has a strong reputation for quality and innovation in the multi ply label sector, which is highly valued by European brand owners, and these significant upgrades strengthen this proposition.

“Kimbolton is now fully equipped to service the single ply pharma, cosmetics and toiletries market.”

According to Farnan, the new investments “significantly enhance” the company’s product and service capabilities and have resulted in increased customer interest.